Ron Epelbaum

Summary

Country: Israel

Publications

  1. doi request reprint Tumor aggressiveness and patient outcome in cancer of the pancreas assessed by dynamic 18F-FDG PET/CT
    Ron Epelbaum
    Department of Oncology, Rambam Health Care Campus and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    J Nucl Med 54:12-8. 2013
  2. pmc Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study
    Wendy Jeanneret-Sozzi
    Centre Hospitalier Universitaire Vaudois and University of Lausanne, Rue du Bugnon, CH 1011 Lausanne, Switzerland
    BMC Cancer 8:86. 2008
  3. ncbi request reprint Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer
    Ron Epelbaum
    Department of Oncology, Rambam Medical Center and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    J Surg Oncol 81:138-43. 2002
  4. doi request reprint Curcumin and gemcitabine in patients with advanced pancreatic cancer
    Ron Epelbaum
    Department of Oncology, Rambam Health Care Campus, Haifa, Israel
    Nutr Cancer 62:1137-41. 2010
  5. doi request reprint A 10-year experience with treatment of high and standard risk Hodgkin disease: six cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preserved
    Eldad J Dann
    Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
    Am J Hematol 87:32-6. 2012
  6. ncbi request reprint Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome
    Eldad J Dann
    Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Haifa, Israel
    Blood 109:905-9. 2007
  7. ncbi request reprint Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment
    Ora Israel
    Department of Nuclear Medicine, Rambam Medical Center, Haifa, Israel
    J Nucl Med 43:1295-303. 2002
  8. doi request reprint (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients
    Michal Weiler-Sagie
    Department of Nuclear Medicine, Rambam Health Care Campus, Haifa, Israel
    J Nucl Med 51:25-30. 2010
  9. doi request reprint FDG avidity and PET/CT patterns in primary gastric lymphoma
    Lea Radan
    Department of Nuclear Medicine, Rambam Health Care Campus, Haifa, Israel
    Eur J Nucl Med Mol Imaging 35:1424-30. 2008
  10. ncbi request reprint Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma
    Zeev Blumenfeld
    Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Fertil Steril 89:166-73. 2008

Detail Information

Publications19

  1. doi request reprint Tumor aggressiveness and patient outcome in cancer of the pancreas assessed by dynamic 18F-FDG PET/CT
    Ron Epelbaum
    Department of Oncology, Rambam Health Care Campus and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    J Nucl Med 54:12-8. 2013
    ..This study aimed to assess the role of a quantitative dynamic PET model in pancreatic cancer as a potential index of tumor aggressiveness and predictor of survival...
  2. pmc Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study
    Wendy Jeanneret-Sozzi
    Centre Hospitalier Universitaire Vaudois and University of Lausanne, Rue du Bugnon, CH 1011 Lausanne, Switzerland
    BMC Cancer 8:86. 2008
    ..To asses the clinical profile, treatment outcome and prognostic factors in primary breast lymphoma (PBL)...
  3. ncbi request reprint Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer
    Ron Epelbaum
    Department of Oncology, Rambam Medical Center and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    J Surg Oncol 81:138-43. 2002
    ..Therefore, a phase II study was conducted to evaluate the efficacy of gemcitabine combined with radiation therapy in patients with localized unresectable adenocarcinoma of the pancreas...
  4. doi request reprint Curcumin and gemcitabine in patients with advanced pancreatic cancer
    Ron Epelbaum
    Department of Oncology, Rambam Health Care Campus, Haifa, Israel
    Nutr Cancer 62:1137-41. 2010
    ..Further studies should be conducted to evaluate the ability of other formulations of curcumin to enhance the effect of chemotherapy in cancer patients...
  5. doi request reprint A 10-year experience with treatment of high and standard risk Hodgkin disease: six cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preserved
    Eldad J Dann
    Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
    Am J Hematol 87:32-6. 2012
    ..Six cycles of tailored BEACOPP, for patients with adverse prognostic factors, provide encouraging long-term PFS and OS, and fertility is preserved in most females...
  6. ncbi request reprint Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome
    Eldad J Dann
    Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Haifa, Israel
    Blood 109:905-9. 2007
    ..02). Early interim fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG)-PET/CT is a useful tool for adjustment of chemotherapy on an individual basis. Similar EFS and OS rates were observed for patients in both risk groups...
  7. ncbi request reprint Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment
    Ora Israel
    Department of Nuclear Medicine, Rambam Medical Center, Haifa, Israel
    J Nucl Med 43:1295-303. 2002
    ..The purpose of the present study was to evaluate the role of 67Ga scintigraphy and CT in treatment monitoring of bone lymphoma...
  8. doi request reprint (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients
    Michal Weiler-Sagie
    Department of Nuclear Medicine, Rambam Health Care Campus, Haifa, Israel
    J Nucl Med 51:25-30. 2010
    ..The aim of the present study is to enlarge the growing body of evidence concerning (18)F-FDG avidity of lymphoma to provide a basis for future guidelines...
  9. doi request reprint FDG avidity and PET/CT patterns in primary gastric lymphoma
    Lea Radan
    Department of Nuclear Medicine, Rambam Health Care Campus, Haifa, Israel
    Eur J Nucl Med Mol Imaging 35:1424-30. 2008
    ..This study assesses FDG avidity and PET/CT patterns in newly diagnosed PGL...
  10. ncbi request reprint Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma
    Zeev Blumenfeld
    Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Fertil Steril 89:166-73. 2008
    ..To minimize the gonadotoxic effect of chemotherapy by the cotreatment with a GnRH agonistic analogue (GnRH-a)...
  11. ncbi request reprint Is 18F-FDG PET/CT useful for imaging and management of patients with suspected occult recurrence of cancer?
    Ora Israel
    Department of Nuclear Medicine, Rambam Medical Center, Haifa 35254, Israel
    J Nucl Med 45:2045-51. 2004
    ....
  12. ncbi request reprint Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma
    Eldad J Dann
    Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center and Bruce Rapaport Faculty of Medicine, Technion, Haifa, Israel 31096
    Hum Reprod 20:2247-9. 2005
    ..4 mg/m2 (maximum 2 mg) and prednisone 100 mg/day were given every 3 weeks)...
  13. ncbi request reprint Clinicopathologic reassessment of non-mycosis fungoides primary cutaneous lymphomas during 17 years
    Reuven Bergman
    Department of Dermatology, Rambam Medical Center, Haifa, Israel
    Int J Dermatol 41:735-43. 2002
    ..The aim of our study was to evaluate the applicability and significance of the new classification systems to the diagnosis and management of non-mycosis fungoides (non-MF) PCL...
  14. pmc A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphoma
    Eldad J Dann
    Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center and Technion, P O Box 9602, Haifa 31096, Israel
    Haematologica 95:1198-206. 2010
    ..Historically, the assessment was based on a static all-or-none scoring system. However, the clinical significance of any positivity in interim FDG-PET/CT has not been defined...
  15. ncbi request reprint Excellent long-term survival in patients with early-stage primary bone lymphoma treated with doxorubicin-based chemotherapy and local radiotherapy
    Moshe Efraim Stein
    Department of Oncology, Rambam Medical Center and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Am J Clin Oncol 25:603-5. 2002
    ..The exact rule of radiation therapy is yet to be determined...
  16. ncbi request reprint Clinical pretreatment risk factors and Ga-67 scintigraphy early during treatment for prediction of outcome of patients with aggressive non-Hodgkin lymphoma
    Ora Israel
    Department of Nuclear Medicine, Rambam Medical Center and the B Rappaport Faculty of Medicine, Israel Institute of Technology, Technion, Haifa, Israel
    Cancer 94:873-8. 2002
    ..Ga-67 scintigraphy during treatment is an early indicator of treatment-related features of lymphoma cells. The ability of risk factors and Ga-67 to predict disease outcome was compared in 139 patients with aggressive NHL...
  17. ncbi request reprint Art therapy improved depression and influenced fatigue levels in cancer patients on chemotherapy
    Gil Bar-Sela
    Division of Oncology, Rambam Health Care Campus, Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Psychooncology 16:980-4. 2007
    ..The purpose of this study was to determine whether improvement in depression, anxiety or fatigue during chemotherapy following anthroposophy art therapy intervention is substantial enough to warrant a controlled trial...
  18. ncbi request reprint Camera-based FDG PET and 67Ga SPECT in evaluation of lymphoma: comparative study
    Rachel Bar-Shalom
    Department of Nuclear Medicine, Rambam Medical Center and the Technion, Israel Institute of Technology, Bat Galim, Haifa 35254, Israel
    Radiology 227:353-60. 2003
    ..To compare gallium 67 (67Ga) scintigraphy and camera-based fluorodeoxyglucose (FDG) positron emission tomography (PET) in the evaluation of patients with lymphoma...
  19. ncbi request reprint Primary spinal epidural lymphoma: patients' profile, outcome, and prognostic factors: a multicenter Rare Cancer Network study
    Virginie Monnard
    Department of Radiation Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
    Int J Radiat Oncol Biol Phys 65:817-23. 2006
    ..To assess the clinical profile, treatment outcome, and prognostic factors in primary spinal epidural lymphoma (PSEL)...